Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Trimmer, Patricia A ^a   Schwartz, Kathleen M ^a   Borland, M Kathleen ^a   De Taboada, Luis ^b   Streeter, Jackson ^b   Oron, Uri ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PhotoThera Inc   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOCHONDRION; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; OXYGEN CONSUMPTION; PARKINSON DISEASE; PATHOGENESIS; PHOTOTHERAPY;

EID: 68249156891     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-26     Document Type: Article

References (64)

1. The heterogeneity of idiopathic Parkinson's disease. T Foltynie C Brayne RA Barker, J Neurol 2002 249 138 145 10.1007/PL00007856 11985378
2. Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. MK Borland PA Trimmer JD Rubinstein PM Keeney K Mohanakumar L Liu JP Bennett Jr, Mol Neurodegener 2008 3 21 19114014 10.1186/1750-1326-3-21
3. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. PK Morrish GV Sawle DJ Brooks, Brain 1996 119 Pt 2 585 591 10.1093/brain/119.2.585 8800950
4. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. AE Lang JA Obeso, Lancet Neurol 2004 3 309 316 10.1016/S1474-4422(04)00740-9 15099546 (Pubitemid 38510202)
5. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. D Sulzer, Trends Neurosci 2007 30 244 250 10.1016/j.tins.2007.03.009 17418429 (Pubitemid 46667168)
6. Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. MP Mattson D Liu, Biochem Biophys Res Commun. 2003 304 3 539 549 10.1016/S0006-291X(03)00627-2 12729589 (Pubitemid 36506527)
7. Role of axonal transport in neurodegenerative diseases. KJ De Vos AJ Grierson S Ackerley CC Miller, Annu Rev Neurosci 2008 31 151 173 10.1146/annurev.neuro.31.061307.090711 18558852
8. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. H Bueler, Exp Neurol 2009 19303005
9. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. B Lach D Grimes B Benoit A Minkiewicz-Janda, Acta Neuropathol(Berl) 1992 83 352 360 10.1007/BF00713525
10. The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor. G Cappelletti T Surrey R Maci, FEBS Lett 2005 579 4781 4786 10.1016/j.febslet.2005.07.058 16098973 (Pubitemid 41218663)
11. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. G Morfini G Pigino K Opalach Y Serulle JE Moreira M Sugimori RR Llinas ST Brady, Proc Natl Acad Sci U S A 2007 104 7 2437 2441 17287339 10.1073/pnas.0611231104 (Pubitemid 46391416)
12. Neurotrophic factors stabilize microtubules and protect against rotenone toxicity on dopaminergic neurons. Q Jiang Z Yan J Feng, J Biol Chem 2006 281 29391 29400 10.1074/jbc.M602740200 16887804 (Pubitemid 44507082)
13. Intrastriatal injection of colchicine induces striatonigral degeneration in mice. Y Liang S Li C Wen Y Zhang Q Guo H Wang B Su, J Neurochem 2008 106 1815 1827 10.1111/j.1471-4159.2008.05526.x 18564367
14. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. AH Schapira, Lancet Neurol 2008 7 97 109 10.1016/S1474-4422(07)70327-7 18093566 (Pubitemid 350251942)
15. Parkinson's disease. B Thomas MF Beal, Hum Mol Genet 2007 16 Spec No 2 R183 194 10.1093/hmg/ddm159 17911161
16. Mitochondrial alterations in Parkinson's disease: new clues. M Vila D Ramonet C Perier, J Neurochem 2008 107 317 328 10.1111/j.1471-4159.2008.05604.x 18680555
17. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. A Bender KJ Krishnan CM Morris GA Taylor AK Reeve RH Perry E Jaros JS Hersheson J Betts T Klopstock, Nat Genet 2006 38 5 515 517 16604074 10.1038/ng1769
18. Mitochondrial ND5 mutations in idiopathic Parkinson's disease. WD Parker Jr JK Parks, Biochem Biophys Res Commun 2005 326 3 667 669 10.1016/j.bbrc.2004. 11.093 15596151 (Pubitemid 39642776)
19. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Y Kraytsberg E Kudryavtseva AC McKee C Geula NW Kowall K Khrapko, Nat Genet 2006 38 5 518 520 10.1038/ng1778 16604072
20. Mitochondrial dynamics in Parkinson's disease. VS Van Laar SB Berman, Exp Neurol 2009 19332061
21. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. CY Chung JB Koprich H Siddiqi O Isacson, J Neurosci 2009 29 3365 3373 10.1523/JNEUROSCI.5427-08.2009 19295143
22. Microtubule: a common target for parkin and Parkinson's disease toxins. J Feng, Neuroscientist 2006 12 469 476 10.1177/1073858406293853 17079513 (Pubitemid 44657962)
23. Creation and characterization of mitochondrial DNA-depleted cell lines with "neuronal-like" properties. SW Miller PA Trimmer WD Parker Jr RE Davis, J Neurochem. 1996 67 5 1897 1907 8863494
24. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. AR Esteves AF Domingues IL Ferreira C Januario RH Swerdlow CR Oliveira SM Cardoso, Mitochondrion 2008 8 219 228 10.1016/j.mito.2008.03.004 18495557
25. Human xenomitochondrial cybrids. Cellular models of mitochondrial complex I deficiency. A Barrientos L Kenyon CT Moraes, J Biol Chem. 1998 273 23 14210 14217 10.1074/jbc.273.23.14210 9603924 (Pubitemid 28319132)
26. Oxidative Stress involvement in alpha-synuclein oligomerization in Parkinsons disease cybrids. AR Esteves DM Arduino RH Swerdlow CR Oliveira SM Cardoso, Antioxid Redox Signal 2008 18717628 18717628
27. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. PA Trimmer MK Borland PM Keeney JP Bennett Jr WD Parker Jr, J Neurochem. 2004 88 4 800 812 14756800
28. Origin and functional consequences of the complex I defect in Parkinson's disease. RH Swerdlow JK Parks SW Miller JB Tuttle PA Trimmer JP Sheehan JP Bennett Jr RE Davis WD Parker Jr, Ann Neurol. 1996 40 4 663 671 10.1002/ana.410400417 8871587 (Pubitemid 26357892)
29. The cybrid model of sporadic Parkinson's disease. PA Trimmer JP Bennett Jr, Exp Neurol 2009 19328199
30. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. PM Keeney J Xie RA Capaldi JP Bennett Jr, J Neurosci 2006 26 5256 5264 10.1523/JNEUROSCI.0984-06. 2006 16687518 (Pubitemid 44315308)
31. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. DS Cassarino JP Bennett Jr, Brain ResBrain ResRev 1999 29 1 25 10.1016/S0165-0173(98)00046-0 (Pubitemid 29016078)
32. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. PA Trimmer RH Swerdlow JK Parks P Keeney JP Bennett Jr SW Miller RE Davis WD Parker Jr, Exp Neurol 2000 162 1 37 50 10716887 10.1006/exnr.2000.7333 (Pubitemid 30170099)
33. Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues. MK Borland KP Mohanakumar JD Rubinstein PM Keeney J Xie R Capaldi LD Dunham PA Trimmer JP Bennett Jr, Biochim Biophys Acta 2008 1792 68 74 18973805
34. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. JT Eells MT Wong-Riley J VerHoeve M Henry EV Buchman MP Kane LJ Gould R Das M Jett BD Hodgson, Mitochondrion 2004 4 559 567 10.1016/j.mito.2004.07.033 16120414 (Pubitemid 39646806)
35. Neuroprotective Effects of Near-Infrared Light in an In Vivo Model of Mitochondrial Optic Neuropathy. JC Rojas J Lee JM John F Gonzalez-Lima, J Neurosci 2008 28 13511 13521 19074024 10.1523/JNEUROSCI.3457-08.2008
36. low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. A Oron U Oron J Streeter TL De A Alexandrovich V Trembovler E Shohami, JNeurotrauma 2007 24 651 656 10.1089/neu.2006.0198 (Pubitemid 46996025)
37. Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury. KR Byrnes RW Waynant IK Ilev X Wu L Barna K Smith R Heckert H Gerst JJ Anders, Lasers SurgMed 2005 36 171 185 10.1002/lsm.20143
38. - 830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: implications for the analgesic effects of 830 nm laser. RT Chow MA David PJ Armati, J Peripher Nerv Syst 2007 12 28 39 10.1111/j.1529-8027.2007.00114.x 17374099 (Pubitemid 46434533)
39. Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. HL Liang HT Whelan JT Eells MT Wong-Riley, Neuroscience 2008 153 963 974 18440709 10.1016/j.neuroscience.2008.03.042
40. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Y Lampl JA Zivin M Fisher R Lew L Welin B Dahlof P Borenstein B Andersson J Perez C Caparo, Stroke 2007 38 1843 1849 10.1161/STROKEAHA.106.478230 17463313 (Pubitemid 46847257)
41. Cell biology: power games. N Lane, Nature 2006 443 901 903 10.1038/443901a 17066004 (Pubitemid 44646147)
42. A novel mitochondrial signaling pathway activated by visible-to-near infrared radiation. TI Karu LV Pyatibrat NI Afanasyeva, PhotochemPhotobiol 2004 80 366 372 10.1562/2004-03-25-RA-123.1
43. Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. V Borutaite A Budriunaite GC Brown, Biochim Biophys Acta 2000 1459 2-3 405 412 11004457 10.1016/S0005-2728(00)00178-X (Pubitemid 30612414)
44. Parkinsonism: onset, progression and mortality. MM Hoehn MD Yahr, Neurology 1967 17 427 442 6067254
45. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. RH Swerdlow, J Neurosci Res 2007 85 3416 3428 10.1002/jnr.21167 17243174 (Pubitemid 350058530)
46. Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. PA Trimmer MK Borland, Antioxid Redox Signal 2005 7 1101 1109 10.1089/ars.2005.7.1101 16115014 (Pubitemid 41232506)
47. Immunological approaches to the characterization and diagnosis of mitochondrial disease. RA Capaldi J Murray L Byrne MS Janes MF Marusich, Mitochondrion 2004 4 417 426 10.1016/j.mito.2004.07.006 16120403 (Pubitemid 39646795)
48. Polarographic oxygen sensor, the oxygraph, and high-resolution respirometry to assess mitochondrial function. E Gnaiger, Drug-Induced Mitochondrial Dysfunction Will JADaY: John Wiley & Sons, Inc 2008 327 352
49. Effects of power densities, continuous and pulse frequencies, and number of sessions of low-level laser therapy on intact rat brain. S Ilic S Leichliter J Streeter A Oron L Detaboada U Oron, PhotomedLaser Surg 2006 24 458 466 10.1089/pho.2006.24.458 (Pubitemid 44689862)
50. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. DS Cassarino CP Fall RH Swerdlow TS Smith EM Halvorsen SW Miller JP Parks WD Parker Jr JP Bennett Jr, Biochim Biophys Acta 1997 1362 77 86 9434102
51. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. JP Sheehan RH Swerdlow WD Parker SW Miller RE Davis JB Tuttle, J Neurochem. 1997 68 3 1221 1233 9048769
52. Complex I and energy thresholds in the brain. RU Pathak GP Davey, Biochim Biophys Acta 2008 1777 777 782 10.1016/j.bbabio.2008.05.443 18519025
53. Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. E Hutter K Renner G Pfister P Stockl P Jansen-Durr E Gnaiger, Biochem J 2004 380 919 928 15018610 10.1042/BJ20040095 (Pubitemid 38850535)
54. Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cells. S Stadlmann K Renner J Pollheimer PL Moser AG Zeimet FA Offner E Gnaiger, Cell Biochem Biophys 2006 44 179 186 10.1385/CBB:44:2:179 16456220 (Pubitemid 43172316)
55. The physiology and pathophysiology of nitric oxide in the brain. FX Guix I Uribesalgo M Coma FJ Mũoz, Progress in Neurobiology 2005 76 126 152 10.1016/j.pneurobio.2005.06.001 16115721 (Pubitemid 41242885)
56. Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. GL Rintoul VJ Bennett NA Papaconstandinou IJ Reynolds, JNeurochem 2006 97 800 806 10.1111/j.1471-4159.2006.03788.x
57. Nitric oxide impairs mitochondrial movement in cortical neurons during hypoxia. SA Zanelli PA Trimmer NJ Solenski, JNeurochem 2006 97 724 736 10.1111/j.1471-4159.2006.03767.x
58. Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. M Stagi PS Dittrich N Frank AI Iliev P Schwille H Neumann, J Neurosci 2005 25 352 362 10.1523/JNEUROSCI.3887-04.2005 15647478 (Pubitemid 40105605)
59. Biostimulative effects of low-energy lasers and their implications for medicine. R Lubart H Breitbart, Drug Development Research 2000 50 471 475 10.1002/1098-2299(200007/08)50:3/4<471::AID-DDR30>3.0.CO;2-E
60. Mitochondrial Signaling in Mammalian Cells Activated by Red and Near-IR Radiation. TI Karu, Photochem Photobiol 2008 84 1091 1099 10.1111/j.1751-1097. 2008.00394.x 18651871
61. The axonal transport of mitochondria. PJ Hollenbeck WM Saxton, JCell Sci 2005 118 5411 5419 10.1242/jcs.02745 (Pubitemid 43079283)
62. ADP regulates movements of mitochondria in neurons. SL Mironov, Biophys J 2007 92 2944 2952 17277190 10.1529/biophysj.106.092981 (Pubitemid 46557867)
63. Mitochondrial swelling impairs the transport of organelles in cerebellar granule neurons. A Kaasik D Safiulina V Choubey M Kuum A Zharkovsky V Veksler, J Biol Chem 2007 282 32821 32826 10.1074/jbc.M702295200 17785462 (Pubitemid 350159289)
64. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. AR Saha J Hill MA Utton AA Asuni S Ackerley AJ Grierson CC Miller AM Davies VL Buchman BH Anderton DP Hanger, JCell Sci 2004 117 1017 1024 10.1242/jcs.00967 (Pubitemid 38456084)